Comparative Tolerability Profiles of Thrombolytic Agents
- 1 January 1993
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 8 (1) , 19-29
- https://doi.org/10.2165/00002018-199308010-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Effect of Intravenous Streptokinase as Compared with That of Tissue Plasminogen Activator on Left Ventricular Function after First Myocardial InfarctionNew England Journal of Medicine, 1989
- Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial InfarctionNew England Journal of Medicine, 1989
- Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Anisoylated Plasminogen Streptokinase Activator Complex versus PlaceboDrugs, 1987
- The Effect of Thrombolytic Therapy with Anisoylated Plasminogen Streptokinase Activator Complex on the Indicators of Myocardial SalvageDrugs, 1987
- Evaluation of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex in Early Myocardial InfarctionDrugs, 1987
- Intracoronary Streptokinase versus Intravenous Anisoylated Plasminogen Streptokinase Activator Complex in the Treatment of Acute Myocardial InfarctionDrugs, 1987
- Achievement of Coronary Artery Patency by Use of Anisoylated Plasminogen Streptokinase Activator Complex in Acute Myocardial InfarctionDrugs, 1987
- A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)New England Journal of Medicine, 1986
- The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1985